F. Hémery
Impact in
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Transplantation top 5%
Papers in
-
- Lymphoma Diagnosis and Treatment 9
- Autoimmune Bullous Skin Diseases 3
-
- Neurofibromatosis and Schwannoma Cases 6
- Co-authors
- FRANÇOIS LEMAIRE (1 shared paper)Jean-Claude Lachérade (1 shared paper)F Bruneel (1 shared paper)Frédérique Schortgen (1 shared paper)Laurent Brochard (1 shared paper)P. Wolkenstein (14 shared papers)Christiane Copie‐Bergman (9 shared papers)Olivier Chosidow (10 shared papers)
- Journals
- British Journal of Dermatology (7 papers)Blood (4 papers)Critical Care (3 papers)European Journal of Clinical Pharmacology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
F. Hémery
61 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 100
- Critical Care and Intensive Care Medicine 340
- Transplantation 94
- Nephrology 198
- Emergency Medicine 184
- Pathology and Forensic Medicine 320
Countries citing papers authored by F. Hémery
This map shows the geographic impact of F. Hémery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Hémery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Hémery more than expected).
Fields of papers citing papers by F. Hémery
This network shows the impact of papers produced by F. Hémery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Hémery. The network helps show where F. Hémery may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Hémery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 520 | |
| 2 | 2005 | 130 | |
| 3 | 2005 | 128 | |
| 4 | 2020 | 101 | |
| 5 | 2005 | 80 | |
| 6 | 2002 | 76 | |
| 7 | 2009 | 73 | |
| 8 | 2015 | 71 | |
| 9 | 2008 | 62 | |
| 10 | 2006 | 56 | |
| 11 | 2008 | 54 | |
| 12 | 2017 | 51 | |
| 13 | 2014 | 44 | |
| 14 | 2015 | 44 | |
| 15 | 2017 | 39 | |
| 16 | 2014 | 36 | |
| 17 | 2012 | 34 | |
| 18 | 2009 | 34 | |
| 19 | 2000 | 32 | |
| 20 | 2011 | 32 |
About F. Hémery
F. Hémery is a scholar working on Pathology and Forensic Medicine, Neurology, Oncology, Genetics and Pharmacology, having authored 64 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Drug-Induced Adverse Reactions (6 papers), Neurofibromatosis and Schwannoma Cases (6 papers), COVID-19 and healthcare impacts (4 papers), Autoimmune Bullous Skin Diseases (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Climate Change and Health Impacts (3 papers) and Streptococcal Infections and Treatments (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (340 citations), Transplantation (94 citations), Nephrology (198 citations), Emergency Medicine (184 citations) and Pathology and Forensic Medicine (320 citations). F. Hémery has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include FRANÇOIS LEMAIRE, Jean-Claude Lachérade, F Bruneel, Frédérique Schortgen, Laurent Brochard, P. Wolkenstein, Christiane Copie‐Bergman, Olivier Chosidow, Christian Brun‐Buisson and É. Sbidian. Their work appears in journals such as British Journal of Dermatology, Blood, Critical Care, European Journal of Clinical Pharmacology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.